BioCentury
ARTICLE | Company News

Management tracks: Medigene, Merck KGaA

August 31, 2018 9:16 PM UTC

Medigene AG (Xetra:MDG1) said CFO Thomas Taapken has resigned. Medigene is seeking a successor. Taapken, who joined the cancer immunotherapy company in January 2017, will continue to advise Medigene as a consultant through the end of the year.

Merck KGaA (Xetra:MRK) promoted Rehan Verjee to president of its biopharmaceuticals subsidiary EMD Serono Inc. and global head of Merck KGaA's innovative medicine franchises. Verjee was Merck KGaA EVP and chief marketing and strategy officer of healthcare...